Encapsulating peritoneal sclerosis in patients on peritoneal dialysis

Netherlands Journal of Medicine

Volumn 66, Issue 7, 2008, Pages 269-274

  Hendriks, M P ^a   de Sevaux R G L ^a   Hilbrands, L B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Encapsulating peritoneal sclerosis; Peritoneal dialysis; Peritonitis; Renal failure

Indexed keywords

AZATHIOPRINE; COLISTIN; CORTICOSTEROID; MEROPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; TACROLIMUS; TAMOXIFEN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABDOMINAL SWELLING; ABSCESS; ADULT; ANOREXIA; ASCITES FLUID; BACTERIAL PERITONITIS; CASE REPORT; DEFECATION DISORDER; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENCAPSULATING PERITONEAL SCLEROSIS; FIBROSIS; GRAFT REJECTION; HEMODIALYSIS; HUMAN; ILEUS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LAPAROSCOPY; MALE; NAUSEA; PARENTERAL NUTRITION; PERITONEAL BIOPSY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONITIS; REVIEW; SMALL INTESTINE PERFORATION; SURGICAL DRAINAGE; VOMITING;

ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL DISEASES; PERITONEUM; SCLEROSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48749083893     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Kawanishi H, Kawaguchi Y, Fukui H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis 2004;44:729-37.
2. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant 1998;13:154-9.
3. Gandhi VC, Humayun HM, Ing TS, et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980;140:1201-3.
4. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000;20(suppl 4):S43-55.
5. Summers AM, Clancy MJ, Syed F, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int 2005;68:2381-8.
6. Korte MR, Yo M, Betjes MG, et al. Increasing incidence of severe encapsulating peritoneal sclerosis after kidney transplantation. Nephrol Dial Transplant 2007;22:2412-4.
7. Fieren MW, Betjes MG, Korte MR, Boer WH. Posttransplant encapsulating peritoneal sclerosis: a worrying new trend? Perit Dial Int 2007;27:619-24.
8. Cancarini GC, Sandrini M, Vizzardi V, Bertoli S, Buzzi L, Maiorca R. Clinical aspects of peritoneal sclerosis. J Nephrol 2001;14(Suppl 4):S39-47.
9. Chin Al, Yeun JY. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am J Kidney Dis 2006;47:697-712.
10. Krediet RT, Zweers MM, van Westrhenen R, Ho-Dac-Pannekeet MM, Struijk DG. What can we do to preserve the peritoneum? Perit Dial Int 2003;23(suppl 2):S14-9.
11. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001;12:1046-51.
12. Ter Wee PM, van Ittersum FJ. The new peritoneal dialysis solutions: friends only, or foes in part? Nat Clin Pract Nephrol 2007;3:604-12.
13. Moriishi M, Kawanishi H, Tsuchiya S. Impact on peritoneal membrane of use of icodextrin-based dialysis solution in peritoneal dialysis patients. Adv Perit Dial 2006;22:24-8.
14. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 1996;28:420-7.
15. Courtney AE, Doherty CC. Fulminant sclerosing peritonitis immediately following acute bacterial peritonitis. Nephrol Dial Transplant 2006;21:532-4.
16. Lin CY, Chen WP, Yang LY, Chen A, Huang TP. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Am J Nephrol 1998;18:513-9.
17. Ghellai AM, Stucchi AF, Chegini N, et al. Role of transforming growth factor beta-1 in peritonitis-induced adhesions. J Gastrointest Surg 2000;4:316-23.
18. Margetts PJ, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003;23:530-41.
19. Khanna A, Cairns V, Hosenpud JD. Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells. Transplantation 1999;67:614-9.
20. Yamamoto R, Otsuka Y, Nakayama M, et al. Risk factors for encapsulating peritoneal sclerosis in patients who have experienced peritoneal dialysis treatment. Clin Exp Nephrol 2005;9:148-52.
21. George C, Al-Zwae K, Nair S, Cast JE. Computed tomography appearances of sclerosing encapsulating peritonitis. Clin Radiol 2007;62:732-7.
22. Garosi G, Di Paolo N, Sacchi G, Gaggiotti E. Sclerosing peritonitis: a nosological entity. Perit Dial Int 2005;25(suppl 3):S110-2.
23. Klimopoulos S, Katsoulis IE, Margellos V, Nikolopoulou N. Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis. J R Coll Surg Edinb 2002;47:485-90.
24. Kawaguchi Y, Saito A, Kawanishi H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int 2005;25(suppl 4):S83-95.
25. Kawanishi H, Watanabe H, Moriishi M, Tsuchiya S. Successful surgical management of encapsulating peritoneal sclerosis. Perit Dial Int 2005;25(suppl 4):S39-47.
26. Moustafellos P, Hadjianastassiou V, Roy D, et al. Tamoxifen therapy in encapsulating sclerosing peritonitis in patients after kidney transplantation. Transplant Proc 2006;38:2913-4.
27. Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosing encapsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol 1999;12:395-7.
28. Eltoum MA, Wright S, Atchley J, Mason JC. Four consecutive cases of peritoneal dialysis-related encapsulating peritoneal sclerosis treated successfully with tamoxifen. Perit Dial Int 2006;2:203-6.
29. Cosman F, Baz-Hecht M, Cushman M, et al. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Thromb Res 2005;116:1-13.
30. Weitz IC, Israel VK, Liebman HA. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden. Cancer 1997;79:2024-7.